AUGUST 2018 – NEWSLETTER – Summit Pain Alliance
This month is full with exciting new projects. Sadly we have to say good bye to one of our providers but we won’t let this slow us down in our efforts of keep offering our patients with the latest technology and advances in pain management. Here at Summit Pain Alliance, we are honored to participate in the development of the most innovative treatments and practices to better serve our patients.
Current studies status:
- Flowonix-Prometra: Active but not enrolling, we have 4 participants remaining in this study.
- Saluda- Evoke: active but not enrolling, we have 4 participants in this study.
- Nevro-Tap10: active and open for enrollment, we recently submitted an abstract for the North American
Neuromodulation Society ( NANS) annual meeting with the preliminary data of our first 5 patients.
- Enso: active with enrollment on hold.